Care Options

CIV Bivalent Vaccine for Dogs: What to Know and Where to Start

The CIV bivalent vaccine for dogs protects against two strains of canine influenza virus, H3N2 and H3N8, and helps reduce the risk of respiratory illness.

Key takeaways

The CIV bivalent vaccine for dogs protects against two strains of canine influenza virus, H3N2 and H3N8, and helps reduce the risk of respiratory illness.

  • Canine influenza is a contagious respiratory infection that can spread between dogs in places such as boarding kennels, daycare facilities, shelters, grooming salons and dog parks.
  • The bivalent vaccine is designed to provide protection against both recognized canine influenza strains rather than just one.
  • It is a non-core vaccine, meaning it is recommended according to a dog's exposure risk and lifestyle rather than automatically required for every dog.
  • Understanding what the vaccine covers, when dogs may benefit from it and what to expect after vaccination can help owners make informed decisions about respiratory disease prevention.

What the Bivalent Vaccine Is

CIV stands for canine influenza virus.

The bivalent vaccine is a veterinary vaccine formulated to protect dogs against two influenza A virus subtypes:

• H3N2: A canine influenza strain associated with outbreaks in dogs in the United States.

• H3N8: Another canine influenza strain that has circulated among dogs and can cause contagious respiratory disease.

The word bivalent means that the vaccine targets two different viral strains. A vaccine that covers only one strain is described as monovalent.

Canine influenza is different from kennel cough, which is a general term for infectious respiratory disease caused by several possible pathogens. Dogs with canine influenza may develop symptoms similar to those caused by other respiratory infections, so a veterinarian may need to perform diagnostic testing to identify the cause.

The bivalent vaccine is intended to reduce the likelihood and severity of illness caused by the two included strains. It does not replace other routine dog vaccinations, such as rabies, distemper and parvovirus vaccines.

How the Vaccine Works and Why Dogs Need It

The bivalent CIV vaccine uses killed canine influenza virus strains to stimulate the dog's immune system.

The immune system recognizes viral components and develops an immune response that helps the dog respond more effectively if exposed to the viruses later.

The vaccine does not contain live, replicating canine influenza virus. USDA records classify the bivalent H3N2/H3N8 formulation as a killed-virus vaccine. The product has been evaluated for protection against both included strains.

Canine influenza spreads primarily through:

• Respiratory droplets released when an infected dog coughs or sneezes.

• Close contact between infected and uninfected dogs.

• Contaminated surfaces, equipment, toys and shared objects.

• Contact with infected dogs in crowded environments.

Dogs are particularly vulnerable in places where many unfamiliar animals interact. Boarding facilities, shelters and daycare centers can create opportunities for respiratory infections to spread.

The initial bivalent vaccination series generally consists of two injections given two to four weeks apart. This schedule allows the immune system to respond to the first dose and develop a stronger response after the second.

The American Animal Hospital Association (AAHA) recommends a booster within one year after the initial series, followed by annual boosters for dogs that need continued protection. The exact administration schedule follows the product label and the dog's vaccination history.

Vaccination works best as part of a broader respiratory disease prevention plan that includes hygiene, appropriate isolation and avoiding contact with visibly sick dogs.

What Vaccination Looks Like in Real Life

For most dogs, receiving the CIV bivalent vaccine is a routine veterinary appointment.

The veterinarian reviews the dog's medical history, checks its health and determines whether the vaccine is appropriate.

The first vaccination does not complete the initial series. Dogs that have never received the vaccine generally need the second injection before the initial course is considered complete.

A typical schedule looks like this:

• Vaccination stage — What happens

• First dose — Initial vaccination against H3N2 and H3N8

• Second dose — Given 2 to 4 weeks after the first

• First booster — Given within one year after the initial series

• Continuing boosters — Generally administered annually

The veterinarian records the vaccination dates and schedules the next appointment. Owners should keep this information because boarding facilities, daycare centers and other dog-care providers sometimes request vaccination documentation.

The vaccine is particularly relevant for dogs that regularly attend group activities. For example, a dog that visits daycare several times a week has more opportunities for exposure than a dog that spends most of its time at home.

A dog that travels frequently also encounters unfamiliar animals and different regional disease patterns. Dogs entering shelters, rescue programs or boarding kennels can face similar exposure risks.

Canine influenza itself can produce several recognizable signs:

• Persistent coughing.

• Sneezing.

• Nasal discharge or a runny nose.

• Eye discharge.

• Fever.

• Reduced appetite.

• Unusual tiredness or low energy.

Some dogs experience mild respiratory symptoms, while others develop more serious illness. Secondary bacterial infections can lead to pneumonia, and some infected dogs show no obvious symptoms.

Most dogs recover from canine influenza within two to three weeks, although more serious infections require veterinary treatment. Breathing difficulty, collapse or rapidly worsening weakness requires emergency veterinary attention.

Risks, Side Effects and Limitations

The CIV bivalent vaccine is not automatically necessary for every dog.

AAHA classifies canine influenza vaccination as non-core, meaning the recommendation depends on lifestyle, geographic location and exposure risk.

Dogs with frequent contact with unfamiliar animals are generally stronger candidates than dogs with limited contact outside their household.

There are several limitations owners should understand.

Protection is specific to the included strains. The bivalent vaccine targets H3N2 and H3N8. It does not protect against every virus or bacterium responsible for canine infectious respiratory disease.

Other respiratory vaccines serve different purposes. Bordetella vaccination, commonly associated with kennel cough prevention, targets a different pathogen. Receiving a Bordetella vaccine does not replace CIV vaccination, and CIV vaccination does not replace appropriate Bordetella protection.

Vaccination does not guarantee complete prevention. A vaccinated dog can still develop respiratory illness, particularly when exposed to other infectious organisms. The vaccine is intended to reduce the risk and severity of disease caused by the included influenza strains.

The two strains do not have equal current importance in the United States. The CDC reports that H3N8 canine influenza has not been reported since 2016 and does not appear to be actively circulating. H3N2 continues to cause localized outbreaks, although it is not considered endemic in the US dog population. This makes current regional H3N2 activity particularly relevant when considering vaccination.

Mild vaccine reactions can occur. Possible reactions include temporary swelling at the injection site, vomiting, diarrhea, lethargy and coughing.

USDA's product-specific safety evaluation included 347 dogs. No adverse events were recorded in 324 dogs. The remaining observations included injection-site swelling and several other symptoms, some of which investigators considered possibly related to vaccination and others unrelated. These findings describe the evaluated product under study conditions rather than predicting an individual dog's reaction.

Dogs with a history of vaccine reactions, significant illness or other medical concerns need an individualized vaccination plan.

What Dog Owners Should Do

The first step is to determine whether canine influenza is a realistic exposure risk for the dog.

Consider the dog's normal activities and upcoming plans. Regular daycare attendance, boarding, dog shows, group training, grooming visits and travel can increase opportunities for contact with infected animals.

Owners can follow these practical steps:

1. Review the dog's vaccination history. Check whether the dog has previously received an H3N2 or H3N8 vaccine, a bivalent CIV vaccine or no influenza vaccination.

1. Check local disease activity. Look for veterinary or animal-health updates about canine influenza outbreaks in the areas where the dog lives, travels or attends group activities.

1. Contact boarding and daycare providers. Ask whether they require CIV vaccination and how far in advance they need the completed vaccination record.

1. Plan the initial series. If vaccination is appropriate, arrange both initial injections and the follow-up booster rather than relying on a single dose.

1. Maintain other preventive vaccinations. Keep rabies, distemper, parvovirus and other recommended vaccines current because the CIV vaccine does not replace them.

1. Monitor respiratory symptoms. Watch for coughing, sneezing, fever, nasal discharge and changes in appetite or energy.

If a dog develops respiratory symptoms, a veterinarian can determine whether canine influenza testing is appropriate. PCR testing can help identify influenza virus in respiratory samples, especially when performed early in the illness. Other infectious organisms can produce similar symptoms, so diagnosis should guide treatment.

Vaccination is preventive rather than a treatment for an existing infection. A dog that is already coughing needs an examination and an appropriate management plan.

Keep vaccination records, follow booster appointments and maintain good hygiene around shared dog-care equipment. Keep a coughing dog away from other dogs and cats until a veterinarian provides instructions for returning to group activities.

Where to Get the CIV Bivalent Vaccine

The CIV bivalent vaccine is available through veterinary providers in the United States.

A general veterinary practice is a good starting point because the veterinarian can assess exposure risk, review existing vaccinations and check which formulation is available.

USDA records identify several licensed bivalent canine influenza vaccine products, including:

• Nobivac Canine Flu Bivalent: A killed-virus vaccine covering H3N2 and H3N8.

• Vanguard CIV H3N2/H3N8: A bivalent canine influenza vaccine.

• TruCan Ultra CIV H3N2/H3N8: Another licensed bivalent canine influenza vaccine.

These products appear in USDA veterinary biologics records under their respective manufacturers. Availability can differ between veterinary practices and regions.

Owners can look for vaccination services through:

• Regular veterinary clinics: Useful for dogs that need a complete vaccination review and an ongoing preventive care plan.

• Animal hospitals: An option for dogs with complicated medical histories or previous vaccine reactions.

• Veterinary vaccination clinics: Some offer preventive vaccination appointments, although CIV vaccine availability should be confirmed beforehand.

• Shelter and rescue veterinary programs: These providers can help with vaccination planning for dogs entering group environments or adoption programs.

When contacting a provider, ask whether the clinic stocks a bivalent H3N2/H3N8 vaccine, whether an initial two-dose series is needed and when the next booster is due.

For dogs that spend considerable time around other animals, an individualized vaccination plan can help reduce the risk of canine influenza and support safer participation in group activities. Bring the dog's vaccination record and information about its exposure to group settings, and ask your veterinarian whether the bivalent vaccine is appropriate.

Frequently asked questions

Is the CIV bivalent vaccine a core vaccine for dogs?

No. Canine influenza vaccination is classified as non-core under AAHA guidelines. It is recommended according to exposure risk, regional disease activity and lifestyle rather than automatically for every dog.

Can a puppy receive the bivalent canine influenza vaccine?

Yes. Certain licensed bivalent products have a minimum recommended starting age of seven weeks. Puppies generally need an initial two-dose series, with the timing determined by the specific product label and veterinary vaccination plan.

Can humans catch canine influenza from vaccinated or infected dogs?

There is no documented evidence of human infection with canine influenza viruses, according to the CDC. Canine H3N2 is different from the seasonal H3N2 influenza virus that circulates among people.

Can a dog have canine influenza without coughing?

Yes. Some infected dogs show no noticeable symptoms. Others develop mild respiratory signs or more serious illness, so the absence of coughing does not rule out infection after a known exposure.

Editorial standards

Who wrote this guide

Written by VetWayfinder Editorial Team.

Every factual statement is tied to a cited source listed below. Report an error through the corrections page.